Robert Donald Harvey

机构：Memorial Sloan Kettering Cancer Center, Emory University · ORCID：0000-0002-4217-1313

发表论文 383 篇 · 总被引 8019 次 · h-index 45

代表论文

A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome (2025 · Cancer Chemotherapy and Pharmacology · 被引 19)
Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement (2024 · Journal of Clinical Oncology · 被引 18)
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors (2024 · Cancer Medicine · 被引 8)
Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology (2025 · Journal of Clinical Oncology · 被引 7)
A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors (2024 · Clinical Therapeutics · 被引 6)
Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab: Highlights From Pharmacists’ Perspectives (2025 · Journal of the Advanced Practitioner in Oncology · 被引 5)